Protection From Lethal Lassa Disease Can Be Achieved Both Before and After Virus Exposure by Administration of Single-Cycle Replicating Lassa Virus Replicon Particles

Lassa fever is a frequently severe human disease that is endemic to several countries in West Africa. To date, no licensed vaccines are available to prevent Lassa virus (LASV) infection, even though Lassa fever is thought to be an important disease contributing to mortality and both acute and chroni...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Infect Dis
Autores principales: Kainulainen, Markus H., Spengler, Jessica R., Welch, Stephen R., Coleman-McCray, JoAnn D., Harmon, Jessica R., Scholte, Florine E. M., Goldsmith, Cynthia S., Nichol, Stuart T., Albariño, César G., Spiropoulou, Christina F.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2019
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6744324/
https://ncbi.nlm.nih.gov/pubmed/31152662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiz284
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares